Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03288051
Other study ID # Free Flap Microcirculation
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 28, 2014
Est. completion date September 19, 2018

Study information

Verified date May 2019
Source Szeged University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Maintaining satisfactory tissue perfusion is an essential of success during reconstructive free flap surgery following malign oral cavity tumours. Intra- and postoperative goal-directed fluid therapy is an appropriate tool for that. Continuous cardiac output monitoring based fluid loading (complemented with vasopressor and/or inotropes if necessary) might be superior to conventional, central venous and arterial pressure monitoring in terms of morbidity, complications, optimal fluid balance and days spent in hospital. However, there is no data describing the effects of goal-directed fluid therapy (crystalloid or colloid) on microcirculation of free flaps implanted in the oral cavity during the post-operative period. The aim of this study is to observe the effects of continuous macrohaemodynamic monitoring based, goal-directed fluid therapy on microcirculation of forearm flaps during the perioperative period.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date September 19, 2018
Est. primary completion date February 28, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age over 18

- Tumour location: intraoral

- Free flap type: radial forearm

- Signed informed concent form

Exclusion Criteria:

- Vulnerable subject as defined in International Standards Organization 14155:2011

- End stage oral cancer

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Fluid management
Primary fluid admission: 1 mL/bodyweight kg/ hour crystalloid. If Pulse pressure variation is lower than 10%; 250 mL/15 min of colloid or crystalloid is administered depending on randomization.
Drug:
Norepinephrine
Norepinephrine is administered if Mean arterial pressure drops below 65 mmHg. Mean arterial pressure must be maintained above 65 mmHg. Norepinephrine is titrated accordingly.
Dobutamine
Dobutamine is administered if Cardiac index drops below 2.5 L/min/m2. Cardiac index must be maintained above 2.5 L/min/m2. Dobutamine is titrated accordingly.

Locations

Country Name City State
Hungary Department of Anaesthesiology and Intensive Therapy Szeged Csongrád

Sponsors (3)

Lead Sponsor Collaborator
Szeged University Department of Oral and Maxillofacial Surgery, University of Szeged, Institute of Surgical Research, University of Szeged

Country where clinical trial is conducted

Hungary, 

References & Publications (3)

Cecconi M, Hofer C, Teboul JL, Pettila V, Wilkman E, Molnar Z, Della Rocca G, Aldecoa C, Artigas A, Jog S, Sander M, Spies C, Lefrant JY, De Backer D; FENICE Investigators; ESICM Trial Group. Fluid challenges in intensive care: the FENICE study: A global inception cohort study. Intensive Care Med. 2015 Sep;41(9):1529-37. doi: 10.1007/s00134-015-3850-x. Epub 2015 Jul 11. Erratum in: Intensive Care Med. 2015 Sep;41(9):1737-8. multiple investigator names added. — View Citation

Hölzle F, Rau A, Loeffelbein DJ, Mücke T, Kesting MR, Wolff KD. Results of monitoring fasciocutaneous, myocutaneous, osteocutaneous and perforator flaps: 4-year experience with 166 cases. Int J Oral Maxillofac Surg. 2010 Jan;39(1):21-8. doi: 10.1016/j.ijom.2009.10.012. Epub 2009 Nov 26. — View Citation

Salzwedel C, Puig J, Carstens A, Bein B, Molnar Z, Kiss K, Hussain A, Belda J, Kirov MY, Sakka SG, Reuter DA. Perioperative goal-directed hemodynamic therapy based on radial arterial pulse pressure variation and continuous cardiac index trending reduces postoperative complications after major abdominal surgery: a multi-center, prospective, randomized study. Crit Care. 2013 Sep 8;17(5):R191. doi: 10.1186/cc12885. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Changes of Pulse pressure variation during the operation and the post-operative 24 hours 24 hours
Primary Assesment of free falp microcirculation by laser dopler flowmetry method. 24 hours
Primary Total need of Norepinephrine and Dobutamine during surgery and the post-operative 24 hours. 24 hours
Primary Changes of Cardiac Index during the operation and the post-operative 24 hours. 24 hours
Primary Mean arterial pressure during the operation and the post-operative 24 hours. 24 hours
Secondary Length of Intensive Care Unit stay 24 hours
Secondary Number of surgical or non-surgical complications. 24 hours
Secondary Length of Hospital stay 10 days